Dr. Susan Faja was named Biomarker Research Principal Investigator for the Innovative Medicine and Precision Approaches to Clinical Trials (IMPACT) Network, an international initiative funded through Aligning Research to Impact Autism (ARIA). Dr. Faja will lead efforts to collect and analyze biomarker and behavioral measures to advance precision approaches to autism research and treatment development.